One trial specifically included participants with MCI who also had concomitant type 2 diabetes (T2D) or insulin resistance, while 2 studies adopted a precision medicine approach by enriching their study populations with individuals carrying the APOE-ε4 allele (Table 1). The gene discussed is APOE; the disease is Insulin resistance.